Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Baudax Bio, Inc. (NASDAQ:BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in p
BBCP, DPRO and PCAR Among Industrial Movers
BBBY, HEXO and ALLO Are Among Pre Market Gainers
PLUG, FCEL and DSX Among Industrial Movers
HC Wainwright Increases Draganfly (NASDAQ:DPRO) Price Target to $2.00
Draganfly (NASDAQ:DPRO – Get Rating) had its price objective hoisted by research analysts at HC Wainwright from $1.50 to $2.00 in a research note issued on Friday, Benzinga reports. The firm current
Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday
SVB Leerink raised the price target for BeiGene, Ltd. (NASDAQ:BGNE) from $236 to $300. SVB Leerink analyst Andrew Berens maintained an Outperform rating. BeiGene shares rose 2% to $279.90 in pre-mar
HC Wainwright Adjusts Price Target on Draganfly to $2 From $1.50, Maintains Buy Rating
07:30 AM EST, 01/20/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
H.C. Wainwright Keeps Their Buy Rating on Draganfly (DPRO)
Draganfly Price Target Raised to $2.00/Share From $1.50 by HC Wainwright & Co.
Draganfly Price Target Raised to $2.00/Share From $1.50 by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Draganfly, Raises Price Target to $2
HC Wainwright & Co. analyst Scott Buck maintains Draganfly with a Buy and raises the price target from $1.5 to $2.
Loading...
No Stock Yet